HMGB1 and colorectal carcinoma: Our previous works have demonstrated a significant association between the release of HMGB1, infiltration of CD8+ TILs, and a favorable survival outcome in CRC patients particularly in patients who received neoadjuvant chemoradiotherapy regimen [29, 33, 55].